In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to ...
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its ...
Pfizer (NYSE:PFE) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer ...
Cook County jury rules heartburn medication Zantac not responsible for plaintiff's cancer; Pfizer settles over 10,000 ...
Pfizer recently filed at least seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication, Nurtec, which is ...
Pharmaceutical giant GSK has won a potentially expensive personal injury case in the US over its heartburn medicine Zantac. Angela Valadez, an 89-year-old woman living in the state of Illinois ...
Pfizer shares have lagged behind the pharma rally due to inflated expectations, one-time losses, write-offs, and the Seagen acquisition. The company is expecting an LOE wave with 6 names facing ...
The key to the investing story is removing the risk of additional Covid sales downside. Pfizer reported Q1'24 revenues of $14.9 billion, with Covid sales of over $2 billion and revenues growing 11 ...
The Judicial Department in Abu Dhabi reached a full settlement for execution files in lawsuits brought by buyers in Wahat Al Zaweya Project.These lawsuits involved a total of 822 execution files, with ...